# PennantPark Floating Rate Capital Ltd.: financial statements, quarterly

PFLT · NYSE · CIK 1504619 · [Other](/sectors/other.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/pflt.md) · [Financials](/companies/pflt/financials.md) · [Filings](/companies/pflt/filings.md) · [Insiders](/companies/pflt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pflt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [28.0 d](/filings/0001193125-25-293672.md) | [22.5](/filings/0000950170-25-017047.md) | [31.1](/filings/0000950170-25-069167.md) | [16.9](/filings/0000950170-25-106537.md) | [21.3 d](/filings/0001193125-25-293672.md) | [28.3](/filings/0001193125-26-042778.md) | [1.2](/filings/0001193125-26-211880.md) | [19.3](/filings/0001193125-26-342352.md) | [17.5 d](/filings/0001193125-25-293672.md) | [(3.6)](/filings/0001193125-26-042778.md) | [28.7](/filings/0001193125-26-211880.md) | [7.6](/filings/0001193125-26-342352.md) |

- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [101](/filings/0000950170-24-130666.md) | [75.8](/filings/0000950170-24-012187.md) | [125](/filings/0000950170-24-055631.md) | [84.6](/filings/0000950170-24-092750.md) | [112](/filings/0001193125-25-293672.md) | [102](/filings/0000950170-25-017047.md) | [111](/filings/0000950170-25-069167.md) | [103](/filings/0000950170-25-106537.md) | [123](/filings/0001193125-25-293672.md) | [55.1](/filings/0001193125-26-042778.md) | [122](/filings/0001193125-26-211880.md) | [101](/filings/0001193125-26-342352.md) |
| Total assets | $m | [1,180](/filings/0000950170-24-130666.md) | [1,359](/filings/0000950170-24-012187.md) | [1,616](/filings/0000950170-24-055631.md) | [1,757](/filings/0000950170-24-092750.md) | [2,109](/filings/0001193125-25-293672.md) | [2,344](/filings/0000950170-25-017047.md) | [2,472](/filings/0000950170-25-069167.md) | [2,522](/filings/0000950170-25-106537.md) | [2,914](/filings/0001193125-26-342352.md) | [2,716](/filings/0001193125-26-042778.md) | [2,748](/filings/0001193125-26-211880.md) | [2,635](/filings/0001193125-26-342352.md) |
| Total liabilities | $m | [526](/filings/0000950170-24-130666.md) | [701](/filings/0000950170-24-012187.md) | [895](/filings/0000950170-24-055631.md) | [940](/filings/0000950170-24-092750.md) | [1,232](/filings/0001193125-25-293672.md) | [1,382](/filings/0000950170-25-017047.md) | [1,405](/filings/0000950170-25-069167.md) | [1,434](/filings/0000950170-25-106537.md) | [1,839](/filings/0001193125-26-342352.md) | [1,676](/filings/0001193125-26-042778.md) | [1,709](/filings/0001193125-26-211880.md) | [1,617](/filings/0001193125-26-342352.md) |
| Shareholders' equity | $m | [654](/filings/0001193125-25-293672.md) | [658](/filings/0000950170-24-055631.md) | [721](/filings/0000950170-25-106537.md) | [817](/filings/0000950170-25-106537.md) | [877](/filings/0001193125-26-342352.md) | [963](/filings/0001193125-26-211880.md) | [1,067](/filings/0001193125-26-342352.md) | [1,088](/filings/0001193125-26-342352.md) | [1,075](/filings/0001193125-26-342352.md) | [1,040](/filings/0001193125-26-211880.md) | [1,039](/filings/0001193125-26-342352.md) | [1,018](/filings/0001193125-26-342352.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [78.2 d](/filings/0001193125-25-293672.md) | [(182)](/filings/0000950170-25-017047.md) | [(173) d](/filings/0000950170-25-069167.md) | [(155) d](/filings/0000950170-25-106537.md) | [(292) d](/filings/0001193125-25-293672.md) | [(233)](/filings/0001193125-26-042778.md) | [(118) d](/filings/0001193125-26-211880.md) | [(35.3) d](/filings/0001193125-26-342352.md) | [(335) d](/filings/0001193125-25-293672.md) | [149](/filings/0001193125-26-042778.md) | [24.3 d](/filings/0001193125-26-211880.md) | [103 d](/filings/0001193125-26-342352.md) |
| Dividends paid | $m | [17.5 d](/filings/0001193125-25-293672.md) | [18.1](/filings/0000950170-25-017047.md) | [18.4 d](/filings/0000950170-25-069167.md) | [20.1 d](/filings/0000950170-25-106537.md) | [22.3 d](/filings/0001193125-25-293672.md) | [24.3](/filings/0001193125-26-042778.md) | [26.8 d](/filings/0001193125-26-211880.md) | [30.0 d](/filings/0001193125-26-342352.md) | [30.5 d](/filings/0001193125-25-293672.md) | [30.5](/filings/0001193125-26-042778.md) | [30.5 d](/filings/0001193125-26-211880.md) | [30.5 d](/filings/0001193125-26-342352.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [45.4](/filings/0000950170-24-012187.md) | [48.5](/filings/0000950170-24-055631.md) | [50.8](/filings/0000950170-24-092750.md) | [58.7](/filings/0000950170-25-017047.md) | [61.2](/filings/0000950170-25-069167.md) | [68.5](/filings/0000950170-25-106537.md) | [81.7](/filings/0001193125-26-042778.md) | [90.1](/filings/0001193125-26-211880.md) | [99.2](/filings/0001193125-26-342352.md) | [99.2](/filings/0001193125-26-042778.md) | [99.2](/filings/0001193125-26-211880.md) | [99.2](/filings/0001193125-26-342352.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 99,217,896 at 2026-08-10, from the cover of the [10-Q filed 2026-08-10](/filings/0001193125-26-342352.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.